2020
DOI: 10.3103/s1068367420040060
|View full text |Cite
|
Sign up to set email alerts
|

Study of Protein Components of Fish Skin Mucus with Thrombogenic Activity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 5 publications
0
1
0
Order By: Relevance
“…As a result, aquatic-derived bioactive compounds have been reported to play a critical role to human health and nutrition. Notable examples include fish-derived clotting factors (Fomina et al, 2020), Seaweed antioxidants (Zerrifi et al, 2018), common water hyacinth, Eichhornia crassipes anticancer phytochemicals (Mtewa et al, 2021), anti-obesity polysaccharides from red algae (Yang et al, 2019), novel conopeptides from marine snails (Zhang et al, 2021), antiinflammatory cembranoids from soft coral (Peng et al, 2020), novel AMPs from sea weed, Porphyra yezoensis (Jiao et al, 2019), anchovy fish-derived antioxidant peptides (Najafian and Babji, 2018), Marine-derived Penicillium purpurogenum anti-tumor metabolites (Teles et al, 2020), Salmon calcitonin anti-glycemic and anti-osteoporosis peptides (Chesnut et al 2008), and fish-derived CF-14 AMPs (Li et al, 2019) among others. Despite, these tremendous contributions to drug leads, majority of the studies seem to focus much few highly valued species of marine habitats, with far limited emphasis on freshwater biochemical compounds.…”
Section: Discussionmentioning
confidence: 99%
“…As a result, aquatic-derived bioactive compounds have been reported to play a critical role to human health and nutrition. Notable examples include fish-derived clotting factors (Fomina et al, 2020), Seaweed antioxidants (Zerrifi et al, 2018), common water hyacinth, Eichhornia crassipes anticancer phytochemicals (Mtewa et al, 2021), anti-obesity polysaccharides from red algae (Yang et al, 2019), novel conopeptides from marine snails (Zhang et al, 2021), antiinflammatory cembranoids from soft coral (Peng et al, 2020), novel AMPs from sea weed, Porphyra yezoensis (Jiao et al, 2019), anchovy fish-derived antioxidant peptides (Najafian and Babji, 2018), Marine-derived Penicillium purpurogenum anti-tumor metabolites (Teles et al, 2020), Salmon calcitonin anti-glycemic and anti-osteoporosis peptides (Chesnut et al 2008), and fish-derived CF-14 AMPs (Li et al, 2019) among others. Despite, these tremendous contributions to drug leads, majority of the studies seem to focus much few highly valued species of marine habitats, with far limited emphasis on freshwater biochemical compounds.…”
Section: Discussionmentioning
confidence: 99%